<?xml version="1.0" encoding="UTF-8"?>
<p>Kidney markers (urea and creatinine) changes were also shown in 
 <xref rid="molecules-26-00487-t003" ref-type="table">Table 3</xref>. The results found that non treated diabetic mice displayed a significant (
 <italic>p</italic> &lt; 0.001) increase in urea and creatinine as compared to normal control. On the other hand, the groups that received the PCS and glibenclamide significantly reduced their creatinine and urea levels in comparison to the diabetic group (
 <italic>p &lt;</italic> 0.001). Their elevated level indicates a progressive renal damage [
 <xref rid="B36-molecules-26-00487" ref-type="bibr">36</xref>] prevented by the administration of different treatments.
</p>
